Adachi K, Kurachi H, Homma H, Adachi H, Imai T, Sakata M, Higashiguchi O, Yamaguchi M, Morishige K, Sakoyama Y
Department of Obstetrics and Gynecology, Osaka University Medical School, Japan.
Endocrinology. 1995 May;136(5):2110-9. doi: 10.1210/endo.136.5.7720660.
We studied the estrogen-dependent expression of epidermal growth factor (EGF), transforming growth factor (TGF) alpha, and EGF receptor gene transcripts in human fallopian tubes in vivo and in vitro. Competitive polymerase chain reaction (PCR) was performed on the fallopian tube RNA samples from the postmenopausal women with or without estrogen replacement. Amounts of EGF, TGF alpha, and EGF receptors gene transcripts in the estrogen-treated group (n = 3) were significantly (P < 0.01) more than those in the untreated group (n = 3). Competitive PCR also showed that EGF, TGF alpha, and EGF receptor gene transcripts level in tubal cells were increased by estrogen in vitro: messenger RNA levels of these factors were significantly (P < 0.01, n = 3) increased in cells incubated with 10(-8) M estrogen compared with those in cells without estrogen treatment. We studied whether EGF and/or TGF alpha is involved in the estrogen-induced tubal cell growth in vitro. Estrogen enhanced the [3H]-thymidine incorporation into the cell in dose- and time-dependent manners in culture: estrogen treatment for more than 12 h significantly (P < 0.05) enhanced the [3H]-thymidine incorporation into the cell at 10(-8) M. The estrogen-induced cell growth was observed in association with the increase in EGF, TGF alpha, and EGF receptor messenger RNA levels by estrogen. If the EGF and/or TGF alpha is involved in the cell growth, then the estrogen-induced cell growth should be suppressed by blocking the action of EGF and/or TGF alpha. Therefore, we examined the effects of neutralizing monoclonal antibodies against EGF, TGF alpha, and EGF receptors. Anti-EGF antibody significantly reduced the estrogen-induced increase in [3H]-thymidine incorporation, whereas anti-TGF alpha antibody failed to show the effect. Anti-EGF receptor antibody showed a significant suppressive effect on the estrogen-induced increase in [3H]-thymidine incorporation. Moreover, the growth inhibitory effect by 1 microgram/ml anti-EGF was restored by 10(-8) M EGF but not by TGF alpha even at 10(-6) M. All these data suggest that estrogen induces EGF and TGF alpha/EGF receptors in the human fallopian tube and that EGF but not TGF alpha may be involved in the estrogen-induced human tubal cell growth in vitro.
我们在体内和体外研究了人输卵管中表皮生长因子(EGF)、转化生长因子(TGF)α和EGF受体基因转录物的雌激素依赖性表达。对接受或未接受雌激素替代治疗的绝经后妇女的输卵管RNA样本进行竞争性聚合酶链反应(PCR)。雌激素治疗组(n = 3)中EGF、TGFα和EGF受体基因转录物的量显著(P < 0.01)高于未治疗组(n = 3)。竞争性PCR还显示,体外雌激素可增加输卵管细胞中EGF、TGFα和EGF受体基因转录物水平:与未用雌激素处理的细胞相比,用10(-8) M雌激素孵育的细胞中这些因子的信使RNA水平显著(P < 0.01,n = 3)升高。我们研究了EGF和/或TGFα是否参与体外雌激素诱导的输卵管细胞生长。雌激素在培养中以剂量和时间依赖性方式增强[3H] - 胸腺嘧啶核苷掺入细胞:雌激素处理超过l2小时,在10(-8) M时显著(P < 0.OS)增强[3H] - 胸腺嘧啶核苷掺入细胞。观察到雌激素诱导的细胞生长与雌激素引起的EGF、TGFα和EGF受体信使RNA水平增加有关。如果EGF和/或TGFα参与细胞生长,那么通过阻断EGF和/或TGFα的作用应可抑制雌激素诱导的细胞生长。因此,我们检测了抗EGF、TGFα和EGF受体的中和单克隆抗体的作用。抗EGF抗体显著降低雌激素诱导的[3H] - 胸腺嘧啶核苷掺入增加,而抗TGFα抗体未显示此作用。抗EGF受体抗体对雌激素诱导的[3H] - 胸腺嘧啶核苷掺入增加有显著抑制作用。此外,1微克/毫升抗EGF的生长抑制作用可被10(-8) M EGF恢复,但即使在10(-6) M时TGFα也不能恢复。所有这些数据表明,雌激素可诱导人输卵管中EGF和TGFα/EGF受体,并且在体外EGF而非TGFα可能参与雌激素诱导的人输卵管细胞生长。